|
|
 |
|
Viewing report
|
|
|
|
The Lifestyle Drugs Outlook To 2008: Unlocking New Value In Well-Being
Business Insights, Oct 2003, Pages: 246
The lifestyle drugs market is currently worth a phenomenal $23bn to boost its value, pharmaceutical companies are actively searching for new lifestyle products and conditions. The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being, provides a timely market update, examining leading products and pipeline prospects in seven key lifestyle drug sectors, and is supported by forecasts to 2008. Today's R&D is influenced as much by commercial unmet needs as it is by clinical opportunities and chance. Pharmaceutical companies must react quickly to these needs if they are to reap greater financial returns. This report can help you to assess the premium associated with different lifestyle drug markets and identify the potential for higher volume sales. Armed with this information your company can formulate winning lifestyle drug development and marketing strategies, and secure a strong competitive position within this market.
Customers who bought this item also bought
Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007
Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
Stakeholder Opinions: Female Sexual Dysfunction - Results From Datamonitors 2005 Physician Survey
U.S. Sexual Dysfunction Medication Markets
Major Milestones: Female Sexual Dysfunction
Female Sexual Dysfunction Therapy Area Pipeline Report
Strategic Perspectives: Female Sexual Dysfunction - Are Physicians and Patients Ready For a Female Viagra?
Male and female sexual dysfunction: Blockbuster indication for multiple pharmacological targets
Womens Health Female Sexual Dysfunction
Erectile Dysfunction Therapy Area Pipeline Report
The World Market For Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry
The Lifestyle Drugs Outlook To 2007: Challenges And Opportunities In A High-Profile Growth Market
|
|
|
|
